510(k) · Cleared
ClearedVMT System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Target Health, Inc. · LXV Apparatus, Vestibular Analysis
Cleared on Oct 5, 1998 as substantially equivalent to K851744 (Neurocom International, Inc., 1985) and 1 other predicate after a 525-day review. Its family tree reaches back 1 generation to 1985.
- Decided
- Oct 5, 1998
- Review
- 525 days
- Class
- Class U
- Product code
- LXV
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K851744 (1985). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK851744 EquitestNeurocom International, Inc. · 1985
- This deviceK971549 VMT SystemTarget Health, Inc. · 1998
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K851744 | Equitest | Neurocom International, Inc. | 1985 | — |
| 0 (this device) | K971549 | VMT System | Target Health, Inc. | 1998 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LXV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LXV device
- #1 K220231 GyroStimscore 3.8 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K851744 | EquitestSummary page 2…me - Ataxiagraph 12.2 Predicate Devices/ Company Names and Addresses The predicate devices are listed below with their 510(K) clearance numbers. The Equitest System - (K851744) NuroCom International, Inc. 9570 SE Lawnfield Road, Clackamas, Oregon 97015-96 USA The Pro & Smart Balance Master Systems - (K9… | 1985 |
| * | K946229 | Balance ManagerSummary page 2…e numbers. The Equitest System - (K851744) NuroCom International, Inc. 9570 SE Lawnfield Road, Clackamas, Oregon 97015-96 USA The Pro & Smart Balance Master Systems - (K946229) NeuroCom International, Inc. 9570 SE Lawnfield Road, Clackamas, Oregon 97015-96 USA 12.3 Clinical Experience Clinical studies… | 1995 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
How does its category compare?
All LXV devicesLXV Apparatus, Vestibular Analysis: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LXV
1in 2022
2026 to Oct 25, outlined.
Median 510(k) review, days · LXV
Too few LXV 510(k)s in any year since 2007 to give a median.
Recalls per year · LXV
1in 2009
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LXV
1in 2010
MAUDE reports naming product code LXV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 1 |
| 2008 | 2 | — | 1 | 0 |
| 2009 | 1 | — | 1 | 0 |
| 2010 | 1 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 1 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The VMT™ System is designed for the evaluation of visuo-motor performance disturbances.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K971549 · printed Nov 6, 2026
Cite this page
510(k) Report. “K971549: VMT System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K971549
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026